Taniborbactam

DB16338InvestigationalSmall molecule

Taniborbactam is under investigation in clinical trial NCT03840148 (Safety and Efficacy Study of Cefepime/vnrx-5133 in Patients With Complicated Urinary Tract Infections).

Formula / weight: C₁₉H₂₈BN₃O₅ · 389.26 g/mol (avg)
Code names: VNRX-5133

Resolves to

Compound

UNII8IGQ156Z07CAS1613267-49-4

Structure

InChIKeyPFZUWUXKQPRWAL-NOLJZWGESA-NSMILESNCCN[C@H]1CC[C@H](CC(=O)N[C@H]2CC3=CC=CC(C(O)=O)=C3OB2O)CC1

Targets

P00807blaZ

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Taniborbactam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account